Skip to main content

Reporter Oct 20 2017

Researchers find novel mechanism of resistance to anti-cancer drugs

Oct. 17, 2017—Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.

Read more


Vanderbilt’s Buntin, Denny elected to National Academy of Medicine

Oct. 16, 2017—Vanderbilt University’s Melinda Buntin, Ph.D., professor of Health Policy and chair of the department, and Joshua Denny, M.D., M.S., professor of Biomedical Informatics and Medicine and Vice President for Personalized Medicine, are among 70 new members elected to the National Academy of Medicine (NAM), the organization announced this week.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more